DATROWAY poudre 100 mg 1 pce
7680698010012
CH-69801
L01FX35
07.16.1.
1 / 2
google
Details
- Product number
- 6980101
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- datopotamabum deruxtecanum 100 mg, saccharum, histidinum, histidini hydrochloridum monohydricum, polysorbatum 80, pro vitro.
Articles (1)
DATROWAY 100 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
Daiichi Sankyo (Schweiz) AG
8048 Zürich
Authorization information
- Swissmedic authorization number
- 69801
- Drug name
- DATROWAY, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- PULPI
- ATC Code
- L01FX35
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 28/05/2025
- Authorization expiration date
- 27/05/2030
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- DATROWAY poudre 100 mg 1 pce
- Description (DE)
- DATROWAY Pulver 100 mg 1 Stk
- Market launch
- 28/07/2025
- Narcotic (BTM)
- No